Causes of Death in Endovascularly Treated Patients with Acute Stroke

References

1. 1.↵
   World Health Organizaton. Global Health Estimates: Life expectancy and leading causes of death and disability. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates. Accessed June 28, 2021
2. 2.↵
   World Health Organizaton. Global health estimates: Leading causes of death—Cause-specific mortality, 2000–2019. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates. Accessed June 28, 2021
3. 3.↵
   1. Feigin VL,
   2. Forouzanfar MH,
   3. Krishnamurthi R, et al

   . Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383:245–54 doi:10.1016/S0140-6736(13)61953-4 pmid:24449944

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Huttner HB,
   2. Schwab S

   . Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol 2009;8:949–58 doi:10.1016/S1474-4422(09)70224-8 pmid:19747656

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Brønnum-Hansen H,
   2. Davidsen M,
   3. Thorvaldsen P

   ; Danish MONICA Study Group. Long-term survival and causes of death after stroke. Stroke 2001;32:2131–36 doi:10.1161/hs0901.094253 pmid:11546907

   Abstract/FREE Full Text
6. 6.↵
   1. Hankey GJ,
   2. Jamrozik K,
   3. Broadhurst RJ, et al

   . Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000;31:2080–86 doi:10.1161/01.STR.31.9.2080 pmid:10978033

   Abstract/FREE Full Text
7. 7.↵
   1. Loor HI,
   2. Groenier KH,
   3. Limburg M, et al

   . Risks and causes of death in a community-based stroke population: 1 month and 3 years after stroke. Neuroepidemiology 1999;18:75–84 doi:10.1159/000069410 pmid:10023130

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Kiyohara Y,
   2. Kubo M,
   3. Kato I, et al

   . Ten-year prognosis of stroke and risk factors for death in a Japanese community. Stroke 2003;34:2343–47 doi:10.1161/01.STR.0000091845.14833.43 pmid:14500930

   Abstract/FREE Full Text
9. 9.↵
   1. Vernino S,
   2. Brown RD,
   3. Sejvar JJ, et al

   . Cause-specific mortality after first cerebral infarction. Stroke 2003;34:1828–32 doi:10.1161/01.STR.0000080534.98416.A0 pmid:12855836

   Abstract/FREE Full Text
10. 10.↵
    1. Hardie K,
    2. Hankey GJ,
    3. Jamrozik K, et al

    . Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke 2003;34:1842–46 doi:10.1161/01.STR.0000082382.42061.EE pmid:12843343

    Abstract/FREE Full Text
11. 11.↵
    1. D'Alton M,
    2. Coughlan T,
    3. Cogan N, et al

    . Patterns of mortality in modern stroke care. Ir Med J 2018;111:750 pmid:30489045

    PubMed
12. 12.↵
    1. Aked J,
    2. Delavaran H,
    3. Lindgren AG

    . Survival, causes of death and recurrence up to 3 years after stroke: a population-based study. Eur J Neurol 2021;28:4060–68 doi:10.1111/e ne.15041 pmid:34327786

    CrossRefPubMed
13. 13.↵
    1. Nogueira RG,
    2. Jadhav AP,
    3. Haussen DC, et al

    . Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

    CrossRefPubMed
14. 14.
    1. Goyal M,
    2. Menon BK,
    3. van Zwam WH, et al

    . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

    CrossRefPubMed
15. 15.↵
    1. Bhatia R,
    2. Hill MD,
    3. Shobha N, et al

    . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254–58 doi:10.1161/STROKEAHA.110.592535 pmid:20829513

    Abstract/FREE Full Text
16. 16.↵
    1. Emberson J,
    2. Lees KR,
    3. Lyden P, et al

    . Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929–35 doi:10.1016/S0140-6736(14)60584-5 pmid:25106063

    CrossRefPubMedWeb of Science
17. 17.
    1. Elakkad A,
    2. Drocton G,
    3. Hui F

    . Endovascular stroke interventions: procedural complications and management. Semin Intervent Radiol 2020;37:199–200 doi:10.1055/s-0040-1709206 pmid:32419733

    CrossRefPubMed
18. 18.↵
    1. Balami JS,
    2. White PM,
    3. McMeekin PJ, et al

    . Complications of endovascular treatment for acute ischemic stroke: prevention and management. Int J Stroke 2018;13:348–61 doi:10.1177/1747493017743051 pmid:29171362

    CrossRefPubMed
19. 19.↵
    1. Nikoubashman O,
    2. Dekeyzer S,
    3. Riabikin A, et al

    . True first-pass effect. Stroke 2019;50:2140–46 doi:10.1161/STROKEAHA.119.025148 pmid:31216965

    CrossRefPubMed
20. 20.↵
    1. Woerdehoff D,
    2. Bredbach GB,
    3. Frohnhofen H, et al

    . Palliativversorgung bei Schlaganfall. NeuroGeriatrie 2014;11:69–73
21. 21.↵
    1. Nikoubashman O,
    2. Schurmann K,
    3. Probst T, et al

    . Clinical impact of ventilation duration in patients with stroke undergoing interventional treatment under general anesthesia: the shorter the better? AJNR Am J Neuroradiol 2016;37:1074–79 doi:10.3174/ajnr.A4680 pmid:26822729

    Abstract/FREE Full Text
22. 22.↵
    1. Liljehult J,
    2. Christensen T,
    3. Christensen KB

    . Early prediction of one-year mortality in ischemic and haemorrhagic stroke. J Stroke Cerebrovasc Dis 2020;29:104667 doi:10.1016/j.jstrokecerebrovasdis.2020.104667 pmid:32044222

    CrossRefPubMed
23. 23.↵
    1. Joundi RA,
    2. Martino R,
    3. Saposnik G, et al

    . Dysphagia screening after intracerebral hemorrhage. Int J Stroke 2018;13:503–10 doi:10.1177/1747493017729265 pmid:28880139

    CrossRefPubMed
24. 24.↵
    1. Olsen TS

    . Stroke recurrence and prognosis after stroke. Handb Clin Neurol 2009;92:407–21 doi:10.1016/S0072-9752(08)01921-0 pmid:18790287

    CrossRefPubMed
25. 25.↵
    1. Diringer MN,
    2. Edwards DF,
    3. Aiyagari V, et al

    . Factors associated with withdrawal of mechanical ventilation in a neurology/neurosurgery intensive care unit. Crit Care Med 2001;29:1792–97 doi:10.1097/00003246-200109000-00023 pmid:11546988

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Verkade MA,
    2. Epker JL,
    3. Nieuwenhoff MD, et al

    . Withdrawal of life-sustaining treatment in a mixed intensive care unit: most common in patients with catastropic brain injury. Neurocrit Care 2012;16:130–35 doi:10.1007/s12028-011-9567-y pmid:21660623

    CrossRefPubMed
27. 27.↵
    1. Singh T,
    2. Peters SR,
    3. Tirschwell DL, et al

    . Palliative care for hospitalized patients with stroke: results from the 2010 to 2012 National Inpatient Sample. Stroke 2017;48:2534–40 doi:10.1161/STROKEAHA.117.016893 pmid:28818864

    Abstract/FREE Full Text
28. 28.↵
    1. Parry-Jones AR,
    2. Paley L,
    3. Bray BD, et al

    ; on behalf of the SSNAP Collaborative Group. Care-limiting decisions in acute stroke and association with survival: analyses of UK national quality register data. Int J Stroke 2016;11:321–31 doi:10.1177/1747493015620806 pmid:28818864

    CrossRefPubMed